Dicerna Pharmaceuticals

URI: https://gptkb.org/entity/Dicerna_Pharmaceuticals
GPTKB entity
Statements (22)
Predicate Object
gptkbp:instanceOf gptkb:biotechnology
gptkbp:acquiredBy gptkb:Novo_Nordisk
gptkbp:acquisitionYear 2021
gptkbp:collaboratedWith gptkb:Boehringer_Ingelheim
gptkb:Eli_Lilly_and_Company
gptkb:Roche
gptkb:Alexion_Pharmaceuticals
gptkbp:country gptkb:United_States
gptkbp:focus RNA interference therapeutics
gptkbp:founded 2006
gptkbp:founder gptkb:James_J._Rossi
gptkbp:headquarters_location gptkb:Lexington,_Massachusetts,_United_States
https://www.w3.org/2000/01/rdf-schema#label Dicerna Pharmaceuticals
gptkbp:industry gptkb:biotechnology
gptkbp:keyPerson gptkb:Douglas_M._Fambrough
gptkbp:product gptkb:Nedosiran
RG6346
gptkbp:stockSymbol gptkb:DRNA
gptkbp:tradedOn gptkb:NASDAQ
gptkbp:website https://www.dicerna.com/
gptkbp:bfsParent gptkb:Novo_Nordisk
gptkbp:bfsLayer 6